SEC Form 4 · accession 0001437749-18-013286
NAVIDEA BIOPHARMACEUTICALS, INC. · NAVB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Frederick O Cope
Officer — SVP & CSO
Period of report
Jun 29, 2018
Accepted (ET)
Jul 13, 2018 · 10:34 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000810509
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 29, 2018 | A | 212,390 | $0.23 | A | 585,052 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Granted in lieu of cash bonus under the 2017 bonus plan.